Technicals Stability Returns

TSR DIY Screener - A flexible way to create powerful strategy
  •   Powerful Strategy Builder
  •   Techno-Funda Filters in One
  •   Auto Refresh/Alerts
  •   TSR Live Plan @991/Yr
Fundamental Analysis of JB Chemicals Pharmaceuticals (JBCHEPHARM)

Summary    Balance Sheet    Cash Flow    Income    Qtrly Income    Valuation Ratio    Profitability Ratios    Solvency    Efficiency Ratios    

Guru Numbers
Book Value/Share276.12
EV/EBITDA20.79
Market Cap (Cr)14805.11
Enterprise Value (Cr)14746.58
Piotroski F-Score7.00
Altman Z Score21.83
Graham No546.53
Price/ Graham 3.50
Peter Lynch Ratio-0.351
Sloan Ratio0.082
Peter Lynch Fair value750.26
Price/ Peter Lynch FV2.55
TSR Fair value1468.93
Key Financial ratios of JBCHEPHARM
Ratio Latest FY Yoy Change TTM MRQ Screener/
About
Price to Earning    31.59 45.83 % 39.82    
Price to Book    5.70 6.59 % 7.36 6.92    
Price to Sales    5.02 3.79 % 5.68    
Earning Per Share    49.86 -13.98 % 48.08 13.59    
Return On Equity    18.06 -27.05 % 18.51 4.92    
Return On Asset    14.78 -26.16 % 15.12 4.03    
Net Profit Margin    15.90 -28.82 % 14.27 13.38    
Operating Profit Margin    19.42 -20.45 % 18.12 18.69    
EBITDA Margin    24.04 -28.25 % 22.26 22.13    
Debt to Equity Ratio    0 0 % 0    
Current Ratio    3.32 -26.12 % 3.32    
Quick Ratio    2.25 -35.42 % 2.25    
View Historitcal ratios of J.B. Chemicals & Pharmaceuticals Ltd.
Valuation Ratios   Profitability Ratio   Solvency Ratios   Efficiency Ratios
Screen Financial Ratio using Custom Screener
Terrific View
Tsr Stability Index - Excellent Score of 94.64
Stock Returns is greater than Nifty returns for consecutive last five years
Piotroski F Score - Good Value of 7.0
Altman Z Score of 21.83 suggests good Stability
Company is Debt Free
Short term positive trend in total sale and net profit
Tremendous increasing in Book Value last 3 year
Company Earning excess return
Steady View
Annual sales of the company is increased for three years in a row
Quarterly sales in last 5 years is trending up
Steady increase in Total Assets for last 3 Years
Steady Growth in EPS for last four quarters
Good Return On Capital Employed of 17.87
Good Return on Equity of 18.51% is achieved by the company
Good Net Margin of 14.27% is achieved by the company
Risky View
Tsr Value Index - Poor Score of 27.78
Price to Book Ratio of 6.93 suggesting that it is very expensive
Very Low Dividend Yield of 0.860 %
Low Earning Yield of 2.60 %
Company is unable to generate enough free cash to support the business.
Terrific Steady Risky Stock View - Fundamental Snapshot
Share Overview
Promoter Owned54.00 %
Institution Owned26.10 %
Public/Others19.90 %
Outstanding Shares7.73 Cr
Floating Shares3.38 Cr
Floating / Outstanding43.76%
Book Value/Share276.12
Face value2.00
Share Holding
Annual Key Income Statement of JBCHEPHARM
Period 31_Mar_2022 31_Mar_2021 Growth
Net Income From Continuing Ops 386.04 448.52 13.93 %
Net Income 385.36 447.96 13.97 %
Operating Income 470.80 489.67 3.85 %
Total Revenue 2424.24 2005.85 20.86 %
Operating Expense 1953.45 798.74 144.57 %
Interest Expense 4.79 6.94 30.98 %
Tax Expense 118.86 148.36 19.88 %
Income Before tax 504.90 596.89 15.41 %
Gross Profit 1581.31 1288.41 22.73 %
Dividend Paid -127.56 -73.24 74.17 %
   
Quarterly Key Income Statement of JBCHEPHARM
Period 30_Jun_2022 31_Mar_2022 Growth
Net Income From Continuing Ops 105.20 84.97 23.81 %
Net Income 105.03 84.84 23.80 %
Operating Income 146.68 102.82 42.66 %
Total Revenue 784.81 624.59 25.65 %
Operating Expense 638.13 521.77 22.30 %
Interest Expense 5.83 1.62 259.88 %
Tax Expense 36.54 18.31 99.56 %
Income Before tax 141.74 103.28 37.24 %
Gross Profit 492.03 411.76 19.49 %
Dividend Paid 0 -127.56 100.00 %
   
Key Balance Sheet Fields
Period 31_Mar_2022 31-Mar-21 Growth
Common Stock 15.46 15.46 0 %
Current Liabilities 383.72 345.27 11.14 %
Total Liabilities 473.28 424.69 11.44 %
Current Assets 1274.86 1552.60 17.89 %
Total Assets 2607.40 2238.12 16.50 %
Working capital 891.14 1207.33 26.19 %
Accounts Payable 224.48 186.92 20.09 %
Inventory 409.96 347.45 17.99 %
Net Receivable 598.12 399.24 49.81 %
   
Key Cash Flow Fields
Period 31_Mar_2022 31_Mar_2021 Growth
Cash EPS 59.30 66.92 11.39 %
Cash From Investment Activity 2.32 -230.68 101.01 %
Cash From Financial Activity -138.39 -87.42 58.30 %
Cash Operational Activity 170.13 314.78 45.95 %
Net Cash Flow 34.07 -3.31 1129.31 %
NetIncome 385.36 447.96 13.97 %
Capital Expenditure 62.87 47.77 31.61 %
Change To Inventory -62.51 -70.09 10.81 %
   



   About JB Chemicals & Pharmaceuticals Limited
J. B. Chemicals & Pharmaceuticals Limited manufactures and markets various pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients in India and internationally. Its principal products include Cilnidipine, Ranitidine, and Metronidazole. The company also provides contract manufacturing services for tablets, lozenges, injectables, gels, creams, ointments, liquid herbal syrups, and capsules; and soft-centered, powder, medicated, and herbal lozenges, as well as various pharmaceutical dosage forms. In addition, it offers a range of contrast media products, including x-ray, magnetic resonance imaging (MRI), and ultrasound scanners. Further, the company provides its services in gastroenterology, hypertension, diabetes, dermatology, nephrology, wound care, anti-infectives, and pharmacovigilance therapeutic areas. J. B. Chemicals & Pharmaceuticals Limited was incorporated in 1976 and is based in Mumbai, India.

Address : Cnergy IT Park, Mumbai, India, 400025

URL : https://www.jbpharma.com

Employee Count : 4340

About TSR TECH Strength / Valuation / Growth

TSR Tech Strength is based on Deep Analysis, Back Testing and Historical Trend Analysis using Machine Learning. Overall Technical Strength is based on 50+ indicators including Technicals, moving Avg, chart patterns, candlestick and proprietary algorithms.Technical Strength is calculate from 5Mins Ticck to One Month Tick

TSR Growth analyses dozen of Historical , MRQ, TTM parameters, returns of Individual Stocks vis-a-vis sector , broad based Index to access Growth Potential

TSR Value analyses dozen of Historical , MRQ, TTM parameters, returns of Individual Stocks vis-a-vis sector , broad based Index to access its value

This is an automated process and in NO WAY should be considered as a tip as its based on past data. We strongly recommend to use these signals for information only and seek advise from a certified professional for any trading decision.If you like it then please share. The more the visitors the more the innovations. Feedback

We are working on fundamental strength also. Please share your views to help shape up the requirement.